October 24, 2018
FDA: Promise Pharmacy recalls one lot of Prednisolone, Gatifloxacin Ophthalmic Solution
Editor's Note
The Food & Drug Administration (FDA) on October 22 announced the recall by Promise Pharmacy (Palm Harbor, Florida) of one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3 mL vials (Lot Number 09042018@2, Exp 12/03/2018).
The recall was issued because the product was found to have unidentified small particulate floating in the solution, which is used as postoperative cataract treatment.
To date the company has not received any reports of adverse events related to the recall.
Free Daily News
- Quality Improvement: Reduce Specimen Labeling Errors
- Staffing Strategy: Grow Your Middle Management
- Olympus issues voluntary labeling update for bronchoscopes used with laser therapy equipment
- NorthStar Anesthesia scales ASC partnerships in Georgia with transparent, clinician-driven model
- Targeted intraoperative radiation slashes pancreatic cancer recurrence to 5%
- Ambient AI reshapes nursing workflows and boosts patient interaction
- Session: Developing a complex spine and total joint service line program in the ASC
- Session: The importance of having a comprehensive plan to prevent workplace violence in ASCs
- Session: Automate to elevate—Streamlining pre-, postoperative processes for better outcomes in ASCs
- Transparent oversight is key to safe surgical innovation
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement